| term overlap_mean setsize_mean score_mean pval_mean overlap_std setsize_std score_std pval_std |
| 2 ltr circle formation 1.0 7.0 10.0 0.0338360956076009 0.0 0.0 0.0 0.0 |
| A tetrasaccharide linker sequence is required for gag synthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir transmembrane transport 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir transport and metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abc family proteins mediated transport 0.0 75.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abc transporter disorders 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abc transporters in lipid homeostasis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic exit in cancer due to rb1 defects 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic g1 s transition in cancer due to rb1 defects 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abortive elongation of hiv 1 transcript in the absence of tat 1.0 23.0 9.391465677179962 0.1070183553885475 0.0 0.0 0.0 0.0 |
| Acetylcholine binding and downstream events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine neurotransmitter release cycle 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine regulates insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acrosome reaction and sperm oocyte membrane binding 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated notch1 transmits signal to the nucleus 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through cdk5 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through frs2 and frs3 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through fyn 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated pkn1 stimulates transcription of ar androgen receptor regulated genes klk2 and klk3 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated tak1 mediates p38 mapk activation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ampk downstream of nmdars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of anterior hox genes in hindbrain development during early embryogenesis 1.0 60.0 3.4891041162227605 0.2560754722464486 0.0 0.0 0.0 0.0 |
| Activation of atr in response to replication stress 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of bad and translocation to mitochondria 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of bh3 only proteins 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of c3 and c5 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of caspases through apoptosome mediated cleavage 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of gene expression by srebf srebp 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of irf3 irf7 mediated by tbk1 ikk epsilon 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of kainate receptors upon glutamate binding 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of matrix metalloproteinases 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nima kinases nek9 nek6 nek7 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nmda receptors and postsynaptic events 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of noxa and translocation to mitochondria 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ppargc1a pgc 1alpha by phosphorylation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of puma and translocation to mitochondria 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 downstream of nmdars 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ras in b cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of smo 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the ap 1 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the mrna upon binding of the cap binding complex and eifs and subsequent binding to 43s 1.0 59.0 3.549612948627727 0.2523879312119707 0.0 0.0 0.0 0.0 |
| Activation of the phototransduction cascade 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the pre replicative complex 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the tfap2 ap 2 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of trka receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of cl 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of dag and tag 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pc 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pe 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pg 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pi 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of ps 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adaptive immune system 3.0 504.0 1.2288189578290227 0.4522175117935607 0.0 0.0 0.0 0.0 |
| Adenylate cyclase activating pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adenylate cyclase inhibitory pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adherens junctions interactions 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adora2b mediated anti inflammatory cytokines production 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 1 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 12 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adrenaline noradrenaline inhibits insulin secretion 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Advanced glycosylation endproduct receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aflatoxin activation and detoxification 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aggrephagy 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the cytosol 1.0 14.0 10.0 0.066549445548378 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the nucleus 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alk mutants bind tkis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha linolenic omega3 and linoleic omega6 acid metabolism 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha oxidation of phytanate 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha protein kinase 1 signaling pathway 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alternative complement activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amino acid transport across the plasma membrane 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amino acids regulate mtorc1 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ampk inhibits chrebp transcriptional activation activity 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amyloid fiber formation 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring fibril formation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring of the basal body to the plasma membrane 0.0 95.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Androgen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anti inflammatory response favouring leishmania parasite infection 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen activates b cell receptor bcr leading to generation of second messengers 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen presentation folding assembly and peptide loading of class i mhc 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen processing cross presentation 1.0 77.0 2.704081632653061 0.3161039234082394 0.0 0.0 0.0 0.0 |
| Antigen processing ubiquitination proteasome degradation 0.0 250.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antimicrobial peptides 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antiviral mechanism by ifn stimulated genes 0.0 73.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc c cdc20 mediated degradation of cyclin b 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc c mediated degradation of cell cycle proteins 0.0 81.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc cdc20 mediated degradation of nek2a 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apex1 independent resolution of ap sites via the single nucleotide replacement pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apobec3g mediated resistance to hiv 1 infection 1.0 4.0 10.0 0.0194745623500658 0.0 0.0 0.0 0.0 |
| Apoptosis 0.0 159.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptosis induced dna fragmentation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cell adhesion proteins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cellular proteins 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic execution phase 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic factor mediated response 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aquaporin mediated transport 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonate production from dag 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonic acid metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arms mediated activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aryl hydrocarbon receptor signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Asparagine n linked glycosylation 0.0 245.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aspartate and asparagine metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly and cell surface presentation of nmda receptors 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of active lpl and lipc lipase complexes 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of collagen fibrils and other multimeric structures 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the hiv virion 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the orc complex at the origin of replication 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Association of tric cct with target proteins during biosynthesis 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Asymmetric localization of pcp proteins 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf4 activates genes in response to endoplasmic reticulum stress 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperone genes 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperones 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attachment and entry 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attachment of gpi anchor to upar 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attenuation phase 1.0 22.0 9.839650145772596 0.1026081339138497 0.0 0.0 0.0 0.0 |
| Auf1 hnrnp d0 binds and destabilizes mrna 1.0 48.0 4.385149804602692 0.2106238865633207 0.0 0.0 0.0 0.0 |
| Aurka activation by tpx2 0.0 73.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Autophagy 1.0 130.0 1.584717607973422 0.4743715197669595 0.0 0.0 0.0 0.0 |
| B wich complex positively regulates rrna expression 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Base excision repair 1.0 55.0 3.8140589569161 0.237457799625543 0.0 0.0 0.0 0.0 |
| Base excision repair ap site formation 1.0 23.0 9.391465677179962 0.1070183553885475 0.0 0.0 0.0 0.0 |
| Basigin interactions 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bbsome mediated cargo targeting to cilium 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta catenin independent wnt signaling 0.0 117.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta catenin phosphorylation cascade 1.0 16.0 10.0 0.0756950383436983 0.0 0.0 0.0 0.0 |
| Beta oxidation of butanoyl coa to acetyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of decanoyl coa to octanoyl coa coa 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of hexanoyl coa to butanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of lauroyl coa to decanoyl coa coa 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of octanoyl coa to hexanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of pristanoyl coa 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of very long chain fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bh3 only proteins associate with and inactivate anti apoptotic bcl 2 members 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bicarbonate transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bile acid and bile salt metabolism 1.0 22.0 9.839650145772596 0.1026081339138497 0.0 0.0 0.0 0.0 |
| Binding and uptake of ligands by scavenger receptors 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Binding of tcf lef ctnnb1 to target gene promoters 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biological oxidations 1.0 94.0 2.206056616194865 0.3713777336871285 0.0 0.0 0.0 0.0 |
| Biosynthesis of epa derived spms 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of maresins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of specialized proresolving mediators spms 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of the n glycan precursor dolichol lipid linked oligosaccharide llo and transfer to a nascent protein 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biotin transport and metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Blood group systems biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bmal1 clock npas2 activates circadian gene expression 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Branched chain amino acid catabolism 1.0 22.0 9.839650145772596 0.1026081339138497 0.0 0.0 0.0 0.0 |
| Budding and maturation of hiv virion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Butyrate response factor 1 brf1 binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Butyrophilin btn family interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| C type lectin receptors clrs 1.0 100.0 2.0711193568336426 0.3898210156701354 0.0 0.0 0.0 0.0 |
| Ca dependent events 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ca2 pathway 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calcineurin activates nfat 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calnexin calreticulin cycle 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Camk iv mediated phosphorylation of creb 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Carboxyterminal post translational modifications of tubulin 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cardiac conduction 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo concentration in the er 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo recognition for clathrin mediated endocytosis 0.0 78.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo trafficking to the periciliary membrane 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Carnitine metabolism 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via death receptors in the presence of ligand 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via dependence receptors in the absence of ligand 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via extrinsic apoptotic signalling pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase mediated cleavage of cytoskeletal proteins 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cation coupled chloride cotransporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd163 mediating an anti inflammatory response 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd209 dc sign signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd22 mediated bcr regulation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 co stimulation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent pi3k akt signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent vav1 pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdc42 gtpase cycle 0.0 134.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdc6 association with the orc origin complex 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdt1 association with the cdc6 orc origin complex 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cell communication 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cell junction organization 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cycle 3.0 613.0 0.9978374607603768 0.5856933595107006 0.0 0.0 0.0 0.0 |
| Cell cycle checkpoints 1.0 257.0 0.7884247448979592 0.7218432931099728 0.0 0.0 0.0 0.0 |
| Cell cycle mitotic 1.0 498.0 0.3962140188067178 0.918730175845906 0.0 0.0 0.0 0.0 |
| Cell death signalling via nrage nrif and nade 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell extracellular matrix interactions 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell junction organization 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell surface interactions at the vascular wall 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular hexose transport 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular response to chemical stress 0.0 133.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular response to heat stress 1.0 93.0 2.230257320319432 0.3682511930157578 0.0 0.0 0.0 0.0 |
| Cellular response to hypoxia 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular response to starvation 1.0 139.0 1.4800354924578527 0.4974171799485529 0.0 0.0 0.0 0.0 |
| Cellular responses to stimuli 3.0 614.0 0.9960998711564578 0.5868250457881288 0.0 0.0 0.0 0.0 |
| Cellular senescence 1.0 131.0 1.572370486656201 0.4769824301569347 0.0 0.0 0.0 0.0 |
| Cgmp effects 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chaperone mediated autophagy 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chemokine receptors bind chemokines 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chk1 chk2 cds1 mediated inactivation of cyclin b cdk1 complex 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chl1 interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cholesterol biosynthesis 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Choline catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate biosynthesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate dermatan sulfate metabolism 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chrebp activates metabolic gene expression 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chromatin modifying enzymes 0.0 210.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chromosome maintenance 2.0 100.0 4.272108843537415 0.086158736226278 0.0 0.0 0.0 0.0 |
| Chylomicron assembly 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron remodeling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cilium assembly 0.0 183.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Circadian clock 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Citric acid cycle tca cycle 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class a 1 rhodopsin like receptors 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class b 2 secretin family receptors 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class i mhc mediated antigen processing presentation 1.0 295.0 0.6838817159516868 0.7704369919046723 0.0 0.0 0.0 0.0 |
| Class i peroxisomal membrane protein import 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Clathrin mediated endocytosis 0.0 119.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 induces nfat activation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 signaling 1.0 85.0 2.444606413994169 0.3426841548479852 0.0 0.0 0.0 0.0 |
| Clec7a inflammasome pathway 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cobalamin cbl vitamin b12 transport and metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Coenzyme a biosynthesis 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cohesin loading onto chromatin 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen biosynthesis and modifying enzymes 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen chain trimerization 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen degradation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen formation 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Common pathway of fibrin clot formation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Competing endogenous rnas cernas regulate pten translation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complement cascade 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complex i biogenesis 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Condensation of prometaphase chromosomes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Condensation of prophase chromosomes 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by aberrant pi3k in cancer 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by akt1 e17k in cancer 1.0 25.0 8.607142857142858 0.1157751708195439 0.0 0.0 0.0 0.0 |
| Constitutive signaling by egfrviii 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by ligand responsive egfr cancer variants 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by overexpressed erbb2 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Conversion from apc c cdc20 to apc c cdh1 in late anaphase 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cooperation of pdcl phlp1 and tric cct in g protein beta folding 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cooperation of prefoldin and tric cct in actin and tubulin folding 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Copi dependent golgi to er retrograde traffic 0.0 83.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Copi independent golgi to er retrograde traffic 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Copi mediated anterograde transport 0.0 89.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Copii mediated vesicle transport 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Costimulation by the cd28 family 1.0 39.0 5.428571428571429 0.1747599807978781 0.0 0.0 0.0 0.0 |
| Creatine metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb phosphorylation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through nmda receptor mediated activation of ras signaling 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of adenylate cyclase 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of camkii camkk camkiv cascasde 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb3 factors activate genes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cristae formation 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Crmps in sema3a signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of particulate exogenous antigens phagosomes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of soluble exogenous antigens endosomes 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Crosslinking of collagen fibrils 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cs ds degradation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ctla4 inhibitory signaling 1.0 17.0 10.0 0.0802348466038066 0.0 0.0 0.0 0.0 |
| Cyclin a b1 b2 associated events during g2 m transition 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyclin a cdk2 associated events at s phase entry 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyclin d associated events in g1 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyp2e1 reactions 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytochrome c mediated apoptotic response 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytochrome p450 arranged by substrate type 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytokine signaling in immune system 2.0 392.0 1.0423076923076924 0.5782691186347382 0.0 0.0 0.0 0.0 |
| Cytoprotection by hmox1 0.0 110.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic iron sulfur cluster assembly 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic sensors of pathogen associated dna 1.0 56.0 3.7443413729128014 0.2412174988663298 0.0 0.0 0.0 0.0 |
| Cytosolic sulfonation of small molecules 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic trna aminoacylation 1.0 24.0 8.982253771073648 0.1114073342812727 0.0 0.0 0.0 0.0 |
| Dag and ip3 signaling 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 interactions 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 signaling 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Darpp 32 events 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dcc mediated attractive signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ddx58 ifih1 mediated induction of interferon alpha beta 1.0 57.0 3.677113702623907 0.2449590299452383 0.0 0.0 0.0 0.0 |
| Deactivation of the beta catenin transactivating complex 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deadenylation dependent mrna decay 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deadenylation of mrna 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Death receptor signalling 1.0 120.0 1.7196021265649115 0.4475497772550058 0.0 0.0 0.0 0.0 |
| Dectin 1 mediated noncanonical nf kb signaling 1.0 53.0 3.9615384615384617 0.2298835505782255 0.0 0.0 0.0 0.0 |
| Dectin 2 family 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt1 causes b4galt1 cdg cdg 2d 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt7 causes eds progeroid type 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective c1galt1c1 causes tnps 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective cftr causes cystic fibrosis 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst14 causes eds musculocontractural type 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst3 causes sedcjd 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst6 causes mcdc1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chsy1 causes tpbs 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ext2 causes exostoses 2 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective f9 activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective factor ix causes hemophilia b 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective factor viii causes hemophilia a 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective galnt3 causes hftc 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective intrinsic pathway for apoptosis 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective lfng causes scdo3 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ripk1 mediated regulated necrosis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in biotin btn metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in cobalamin b12 metabolism 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in vitamin and cofactor metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects of contact activation system cas and kallikrein kinin system kks 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of axin 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of beta catenin by the destruction complex 1.0 77.0 2.704081632653061 0.3161039234082394 0.0 0.0 0.0 0.0 |
| Degradation of cysteine and homocysteine 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of dvl 0.0 50.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of gli1 by the proteasome 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of the extracellular matrix 1.0 56.0 3.7443413729128014 0.2412174988663298 0.0 0.0 0.0 0.0 |
| Depolymerisation of the nuclear lamina 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deposition of new cenpa containing nucleosomes at the centromere 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dermatan sulfate biosynthesis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Detoxification of reactive oxygen species 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deubiquitination 0.0 221.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Developmental biology 2.0 665.0 0.5959653092006033 0.8466680851063382 0.0 0.0 0.0 0.0 |
| Dex h box helicases activate type i ifn and inflammatory cytokines production 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion and absorption 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disassembly of the destruction complex and recruitment of axin to the membrane 1.0 24.0 8.982253771073648 0.1114073342812727 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosaminoglycan metabolism 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosylation precursor biosynthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with n glycosylation of proteins 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with o glycosylation of proteins 1.0 17.0 10.0 0.0802348466038066 0.0 0.0 0.0 0.0 |
| Diseases associated with surfactant metabolism 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of base excision repair 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of carbohydrate metabolism 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of dna repair 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of glycosylation 1.0 76.0 2.740408163265306 0.312708212996757 0.0 0.0 0.0 0.0 |
| Diseases of immune system 1.0 15.0 10.0 0.0711332726649859 0.0 0.0 0.0 0.0 |
| Diseases of metabolism 2.0 131.0 3.23546511627907 0.1349531687426338 0.0 0.0 0.0 0.0 |
| Diseases of mismatch repair mmr 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of mitotic cell cycle 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of programmed cell death 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of signal transduction by growth factor receptors and second messengers 4.0 333.0 2.59468745870226 0.079701490259028 0.0 0.0 0.0 0.0 |
| Disinhibition of snare formation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disorders of transmembrane transporters 0.0 115.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Displacement of dna glycosylase by apex1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dissolution of fibrin clot 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage bypass 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage recognition in gg ner 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage reversal 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage telomere stress induced senescence 1.0 38.0 5.575841147269719 0.1706778675257841 0.0 0.0 0.0 0.0 |
| Dna double strand break repair 0.0 137.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna double strand break response 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna methylation 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna repair 2.0 291.0 1.4211361014994233 0.4199164377836463 0.0 0.0 0.0 0.0 |
| Dna replication 0.0 137.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna replication initiation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna replication pre initiation 0.0 92.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna strand elongation 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dopamine clearance from the synaptic cleft 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dopamine neurotransmitter release cycle 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 erbb3 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb4 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of smad2 3 smad4 transcriptional activity 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of tgf beta receptor signaling 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signal transduction 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling events of b cell receptor bcr 1.0 71.0 2.9376093294460643 0.295480255529908 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr1 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr2 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr3 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr4 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dscam interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in gg ner 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in tc ner 1.0 67.0 3.116883116883117 0.2813938178053637 0.0 0.0 0.0 0.0 |
| E2f enabled inhibition of pre replication complex formation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| E2f mediated regulation of dna replication 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| E3 ubiquitin ligases ubiquitinate target proteins 1.0 40.0 5.2888540031397175 0.1788224008957527 0.0 0.0 0.0 0.0 |
| Early phase of hiv life cycle 1.0 13.0 10.0 0.0619434524836269 0.0 0.0 0.0 0.0 |
| Ecm proteoglycans 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Effects of pip2 hydrolysis 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr downregulation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr interacts with phospholipase c gamma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr transactivation by gastrin 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egr2 and sox10 mediated initiation of schwann cell myelination 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eicosanoids 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elastic fibre formation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Electric transmission across gap junctions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elevation of cytosolic ca2 levels 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endogenous sterols 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endosomal sorting complex required for transport escrt 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endosomal vacuolar pathway 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Energy dependent regulation of mtor by lkb1 ampk 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Enos activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eph ephrin mediated repulsion of cells 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eph ephrin signaling 0.0 80.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Epha mediated growth cone collapse 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ephb mediated forward signaling 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ephrin signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Epigenetic regulation of gene expression 1.0 102.0 2.0297029702970297 0.3958501174260305 0.0 0.0 0.0 0.0 |
| Er quality control compartment erqc 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Er to golgi anterograde transport 0.0 129.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erbb2 activates ptk6 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erbb2 regulates cell motility 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ercc6 csb and ehmt2 g9a positively regulate rrna expression 1.0 27.0 7.943485086342229 0.1244478155008913 0.0 0.0 0.0 0.0 |
| Erk mapk targets 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erks are inactivated 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up carbon dioxide and release oxygen 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up oxygen and release carbon dioxide 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phosphoinositide 3 kinase pi3k 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phospholipase c gamma plcg 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates ras 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates stat5 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Esr mediated signaling 2.0 136.0 3.11318407960199 0.1433250213961272 0.0 0.0 0.0 0.0 |
| Establishment of sister chromatid cohesion 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen dependent gene expression 1.0 90.0 2.306122448979592 0.3587798531269947 0.0 0.0 0.0 0.0 |
| Estrogen dependent nuclear events downstream of esr membrane signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen stimulated signaling through prkcz 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ethanol oxidation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eukaryotic translation elongation 1.0 89.0 2.332560296846012 0.3555919235953944 0.0 0.0 0.0 0.0 |
| Eukaryotic translation initiation 1.0 116.0 1.7801242236024846 0.4364495014109603 0.0 0.0 0.0 0.0 |
| Export of viral ribonucleoproteins from nucleus 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Extension of telomeres 1.0 52.0 4.039615846338536 0.2260688267312995 0.0 0.0 0.0 0.0 |
| Extra nuclear estrogen signaling 1.0 47.0 4.48092280390417 0.2067156970649581 0.0 0.0 0.0 0.0 |
| Extracellular matrix organization 1.0 131.0 1.572370486656201 0.4769824301569347 0.0 0.0 0.0 0.0 |
| Extrinsic pathway of fibrin clot formation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Factors involved in megakaryocyte development and platelet production 1.0 117.0 1.7646023926812104 0.4392448907866976 0.0 0.0 0.0 0.0 |
| Fanconi anemia pathway 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fasl cd95l signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acid metabolism 0.0 117.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acids bound to gpr40 ffar1 regulate insulin secretion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acyl coa biosynthesis 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fbxw7 mutants and notch1 in cancer 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fc epsilon receptor fceri signaling 1.0 108.0 1.9147434674804504 0.4135892767062017 0.0 0.0 0.0 0.0 |
| Fceri mediated ca 2 mobilization 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated mapk activation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated nf kb activation 1.0 68.0 3.070057873895827 0.2849410889163232 0.0 0.0 0.0 0.0 |
| Fcgamma receptor fcgr dependent phagocytosis 0.0 72.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fcgr activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fcgr3a mediated il10 synthesis 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fertilization 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 mutant receptor activation 1.0 22.0 9.839650145772596 0.1026081339138497 0.0 0.0 0.0 0.0 |
| Fgfr1b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 alternative splicing 1.0 26.0 8.26204081632653 0.1201219647894398 0.0 0.0 0.0 0.0 |
| Fgfr2 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 mutant receptor activation 1.0 18.0 10.0 0.0847528009868792 0.0 0.0 0.0 0.0 |
| Fgfr2b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3 ligand binding and activation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3b ligand binding and activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfrl1 modulation of fgfr1 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fibronectin matrix formation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling by cbl mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling in disease 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling through src family kinases 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Folding of actin by cct tric 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of apoptosome 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of atp by chemiosmotic coupling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of fibrin clot clotting cascade 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of incision complex in gg ner 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of rna pol ii elongation complex 2.0 58.0 7.507440476190476 0.0327224420542492 0.0 0.0 0.0 0.0 |
| Formation of senescence associated heterochromatin foci sahf 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of tc ner pre incision complex 1.0 53.0 3.9615384615384617 0.2298835505782255 0.0 0.0 0.0 0.0 |
| Formation of the beta catenin tcf transactivating complex 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the cornified envelope 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the early elongation complex 1.0 33.0 6.450255102040816 0.1499686155438198 0.0 0.0 0.0 0.0 |
| Formation of tubulin folding intermediates by cct tric 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of xylulose 5 phosphate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formyl peptide receptors bind formyl peptides and many other ligands 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell cycle genes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell death genes 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of oxidative stress metabolic and neuronal genes 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Free fatty acids regulate insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr1 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr2 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr3 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr4 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha 12 13 signalling events 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha i signalling events 0.0 88.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha q signalling events 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha s signalling events 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha z signalling events 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through cdc42 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through pi3kgamma 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein activation 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein beta gamma signalling 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein mediated events 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G0 and early g1 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G1 s dna damage checkpoints 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G1 s specific transcription 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 m checkpoints 0.0 134.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 m dna damage checkpoint 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 m dna replication checkpoint 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 phase 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gab1 signalosome 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba b receptor activation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba receptor activation 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba synthesis release reuptake and degradation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Galactose catabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gamma carboxylation hypusine formation and arylsulfatase activation 1.0 29.0 7.37463556851312 0.1330370821365251 0.0 0.0 0.0 0.0 |
| Gamma carboxylation transport and amino terminal cleavage of proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap filling dna repair synthesis and ligation in gg ner 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction assembly 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction degradation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction trafficking and regulation 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gastrin creb signalling pathway via pkc and mapk 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gdp fucose biosynthesis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gene and protein expression by jak stat signaling after interleukin 12 stimulation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gene silencing by rna 1.0 75.0 2.7777164920022064 0.3092959809067388 0.0 0.0 0.0 0.0 |
| Generation of second messenger molecules 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gli proteins bind promoters of hh responsive genes to promote transcription 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Global genome nucleotide excision repair gg ner 0.0 87.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon like peptide 1 glp1 regulates insulin secretion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon signaling in metabolic regulation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon type ligand receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gluconeogenesis 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucose metabolism 0.0 80.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucuronidation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutamate and glutamine metabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutamate neurotransmitter release cycle 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutathione conjugation 1.0 21.0 10.0 0.0981765691424607 0.0 0.0 0.0 0.0 |
| Glutathione synthesis and recycling 1.0 8.0 10.0 0.0385773062479974 0.0 0.0 0.0 0.0 |
| Glycerophospholipid biosynthesis 0.0 86.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycerophospholipid catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen breakdown glycogenolysis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen metabolism 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen storage diseases 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen synthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycolysis 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycosaminoglycan metabolism 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycosphingolipid metabolism 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glyoxylate metabolism and glycine degradation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi associated vesicle biogenesis 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi cisternae pericentriolar stack reorganization 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi to er retrograde transport 0.0 115.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gp1b ix v activation signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gpcr ligand binding 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gpvi mediated activation cascade 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 sos provides linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb7 events in erbb2 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Growth hormone receptor signaling 1.0 15.0 10.0 0.0711332726649859 0.0 0.0 0.0 0.0 |
| Hats acetylate histones 0.0 90.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hcmv early events 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hcmv infection 0.0 102.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hcmv late events 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdacs deacetylate histones 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl assembly 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl clearance 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl remodeling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdms demethylate histones 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through homologous recombination hrr 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through mmej alt nhej 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through single strand annealing ssa 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hedgehog ligand biogenesis 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hedgehog off state 0.0 96.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hedgehog on state 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Heme biosynthesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Heme degradation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Heme signaling 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hemostasis 3.0 361.0 1.7451563057173425 0.2601152732882323 0.0 0.0 0.0 0.0 |
| Heparan sulfate heparin hs gag metabolism 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly calcium permeable nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Histidine catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hiv elongation arrest and recovery 1.0 32.0 6.658986175115207 0.1457663642848915 0.0 0.0 0.0 0.0 |
| Hiv infection 2.0 213.0 1.9618878357030016 0.2807980004527436 0.0 0.0 0.0 0.0 |
| Hiv life cycle 2.0 144.0 2.9354460093896715 0.1569435616805101 0.0 0.0 0.0 0.0 |
| Hiv transcription elongation 1.0 42.0 5.029865604778497 0.1868885334554594 0.0 0.0 0.0 0.0 |
| Hiv transcription initiation 1.0 45.0 4.6855287569573285 0.1988423464133734 0.0 0.0 0.0 0.0 |
| Homologous dna pairing and strand exchange 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Homology directed repair 0.0 106.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Host interactions of hiv factors 1.0 116.0 1.7801242236024846 0.4364495014109603 0.0 0.0 0.0 0.0 |
| Hs gag biosynthesis 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hs gag degradation 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hsf1 activation 1.0 25.0 8.607142857142858 0.1157751708195439 0.0 0.0 0.0 0.0 |
| Hsf1 dependent transactivation 1.0 30.0 7.11963406052076 0.1373006943976843 0.0 0.0 0.0 0.0 |
| Hsp90 chaperone cycle for steroid hormone receptors shr in the presence of ligand 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hur elavl1 binds and stabilizes mrna 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan biosynthesis and export 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan metabolism 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan uptake and degradation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hydrolysis of lpc 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ikba variant leads to eda id 1.0 7.0 10.0 0.0338360956076009 0.0 0.0 0.0 0.0 |
| Ikk complex recruitment mediated by rip1 1.0 16.0 10.0 0.0756950383436983 0.0 0.0 0.0 0.0 |
| Il 6 type cytokine receptor ligand interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Immunoregulatory interactions between a lymphoid and a non lymphoid cell 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of cdc42 and rac1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of csf3 g csf signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Incretin synthesis secretion and inactivation 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Infection with mycobacterium tuberculosis 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Infectious disease 3.0 619.0 0.9874965460071844 0.5924553466263829 0.0 0.0 0.0 0.0 |
| Inflammasomes 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Influenza infection 2.0 150.0 2.8147522522522523 0.1673171702489807 0.0 0.0 0.0 0.0 |
| Inhibition of dna recombination at telomere 2.0 28.0 10.0 0.0082126449787597 0.0 0.0 0.0 0.0 |
| Inhibition of replication initiation of damaged dna by rb1 e2f1 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initial triggering of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initiation of nuclear envelope ne reformation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inla mediated entry of listeria monocytogenes into host cells 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inlb mediated entry of listeria monocytogenes into host cell 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Innate immune system 2.0 624.0 0.6379957127545552 0.8195752091361015 0.0 0.0 0.0 0.0 |
| Inositol phosphate metabolism 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insertion of tail anchored proteins into the endoplasmic reticulum membrane 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin processing 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin receptor recycling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin receptor signalling cascade 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of energy metabolism 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of provirus 1.0 9.0 10.0 0.0432957136582515 0.0 0.0 0.0 0.0 |
| Integrin cell surface interactions 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integrin signaling 1.0 18.0 10.0 0.0847528009868792 0.0 0.0 0.0 0.0 |
| Interaction between l1 and ankyrins 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interaction with cumulus cells and the zona pellucida 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interactions of rev with host cellular proteins 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interactions of vpr with host cellular proteins 1.0 37.0 5.7312925170068025 0.1665759675679584 0.0 0.0 0.0 0.0 |
| Interconversion of nucleotide di and triphosphates 1.0 26.0 8.26204081632653 0.1201219647894398 0.0 0.0 0.0 0.0 |
| Interferon alpha beta signaling 1.0 31.0 6.881632653061224 0.141543756104335 0.0 0.0 0.0 0.0 |
| Interferon gamma signaling 1.0 51.0 4.120816326530612 0.2222355866483168 0.0 0.0 0.0 0.0 |
| Interferon signaling 1.0 128.0 1.609995179174032 0.4691113225455097 0.0 0.0 0.0 0.0 |
| Interleukin 1 family signaling 1.0 95.0 2.182370820668693 0.3744891089864141 0.0 0.0 0.0 0.0 |
| Interleukin 1 processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 1 signaling 1.0 82.0 2.5359032501889645 0.3328373805982222 0.0 0.0 0.0 0.0 |
| Interleukin 10 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 12 family signaling 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 12 signaling 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 15 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 17 signaling 1.0 57.0 3.677113702623907 0.2449590299452383 0.0 0.0 0.0 0.0 |
| Interleukin 2 family signaling 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 2 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 20 family signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 21 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 23 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 27 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 3 interleukin 5 and gm csf signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 35 signalling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 36 pathway 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 37 signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 4 and interleukin 13 signaling 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 6 family signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 6 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 7 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 9 signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin receptor shc signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intra golgi and retrograde golgi to er traffic 0.0 181.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intra golgi traffic 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intracellular signaling by second messengers 2.0 233.0 1.7884199134199137 0.3172349169334806 0.0 0.0 0.0 0.0 |
| Intraflagellar transport 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intrinsic pathway for apoptosis 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intrinsic pathway of fibrin clot formation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inwardly rectifying k channels 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion channel transport 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion homeostasis 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion transport by p type atpases 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ionotropic activity of kainate receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak1 recruits ikk complex 1.0 12.0 10.0 0.0573151884822011 0.0 0.0 0.0 0.0 |
| Irak2 mediated activation of tak1 complex 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak4 deficiency tlr2 4 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ire1alpha activates chaperones 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irf3 mediated activation of type 1 ifn 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irf3 mediated induction of type i ifn 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Iron uptake and transport 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irs activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irs mediated signalling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Jnk c jun kinases phosphorylation and activation mediated by activated human tak1 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Josephin domain dubs 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate degradation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate keratin metabolism 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratinization 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ketone body metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Killing mechanisms 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Kinesins 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ksrp khsrp binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| L1cam interactions 0.0 91.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lagging strand synthesis 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Laminin interactions 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Late endosomal microautophagy 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ldl clearance 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ldl remodeling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Leishmania infection 0.0 110.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lgi adam interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Linoleic acid la metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipid particle organization 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipophagy 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Listeria monocytogenes entry into host cells 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Long term potentiation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of function of mecp2 in rett syndrome 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of function of smad2 3 in cancer 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of mecp2 binding ability to the ncor smrt complex 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lrr flii interacting protein 1 lrrfip1 activates type i ifn production 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysine catabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysosome vesicle biogenesis 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysosphingolipid and lpa receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| M phase 1.0 355.0 0.564510549982705 0.8307293097504086 0.0 0.0 0.0 0.0 |
| Map2k and mapk activation 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Map3k8 tpl2 dependent mapk1 3 activation 1.0 14.0 10.0 0.066549445548378 0.0 0.0 0.0 0.0 |
| Mapk family signaling cascades 2.0 212.0 1.9714285714285715 0.2789713511075724 0.0 0.0 0.0 0.0 |
| Mapk targets nuclear events mediated by map kinases 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk1 erk2 activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk3 erk1 activation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk6 mapk4 signaling 1.0 77.0 2.704081632653061 0.3161039234082394 0.0 0.0 0.0 0.0 |
| Mastl facilitates mitotic progression 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of protein 3a 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 nucleoprotein 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 spike protein 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 nucleoprotein 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 spike protein 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates neuronal receptors and channels 1.0 12.0 10.0 0.0573151884822011 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription of neuronal ligands 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiosis 1.0 54.0 3.8864073931459377 0.2336798458054532 0.0 0.0 0.0 0.0 |
| Meiotic recombination 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiotic synapsis 1.0 31.0 6.881632653061224 0.141543756104335 0.0 0.0 0.0 0.0 |
| Membrane trafficking 2.0 532.0 0.7559748427672957 0.7433082362328878 0.0 0.0 0.0 0.0 |
| Met activates pi3k akt signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ptk2 signaling 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ptpn11 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates rap1 and rac1 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ras signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met interacts with tns proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met promotes cell motility 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met receptor activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met receptor recycling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolic disorders of biological oxidation enzymes 1.0 13.0 10.0 0.0619434524836269 0.0 0.0 0.0 0.0 |
| Metabolism of amine derived hormones 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of amino acids and derivatives 4.0 281.0 3.09810076911003 0.0483442258897045 0.0 0.0 0.0 0.0 |
| Metabolism of angiotensinogen to angiotensins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of carbohydrates 1.0 201.0 1.0148979591836735 0.631365625598012 0.0 0.0 0.0 0.0 |
| Metabolism of cofactors 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of fat soluble vitamins 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of folate and pterines 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of ingested semet sec mesec into h2se 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of lipids 2.0 508.0 0.7938076416337286 0.719463262210565 0.0 0.0 0.0 0.0 |
| Metabolism of nitric oxide nos3 activation and regulation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of nucleotides 1.0 82.0 2.5359032501889645 0.3328373805982222 0.0 0.0 0.0 0.0 |
| Metabolism of polyamines 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of porphyrins 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of rna 8.0 647.0 2.8338922423429467 0.0126567323019132 0.0 0.0 0.0 0.0 |
| Metabolism of steroid hormones 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of steroids 1.0 103.0 2.009603841536615 0.3988427362229673 0.0 0.0 0.0 0.0 |
| Metabolism of vitamins and cofactors 0.0 134.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of water soluble vitamins and cofactors 0.0 91.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metal ion slc transporters 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metalloprotease dubs 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metallothioneins bind metals 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Methionine salvage pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Methylation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mhc class ii antigen presentation 1.0 100.0 2.0711193568336426 0.3898210156701354 0.0 0.0 0.0 0.0 |
| Microrna mirna biogenesis 1.0 24.0 8.982253771073648 0.1114073342812727 0.0 0.0 0.0 0.0 |
| Miro gtpase cycle 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous substrates 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous transport and binding events 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mismatch repair 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial biogenesis 0.0 85.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial calcium ion transport 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of saturated fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of unsaturated fatty acids 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial iron sulfur cluster biogenesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial protein import 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial translation 3.0 93.0 7.131914893617021 0.0105674519890882 0.0 0.0 0.0 0.0 |
| Mitochondrial trna aminoacylation 1.0 23.0 9.391465677179962 0.1070183553885475 0.0 0.0 0.0 0.0 |
| Mitochondrial uncoupling 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitophagy 1.0 24.0 8.982253771073648 0.1114073342812727 0.0 0.0 0.0 0.0 |
| Mitotic g1 phase and g1 s transition 0.0 143.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitotic g2 g2 m phases 0.0 186.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitotic metaphase and anaphase 1.0 225.0 0.9039723032069972 0.6732141998385435 0.0 0.0 0.0 0.0 |
| Mitotic prometaphase 1.0 198.0 1.0306640422666529 0.6257786575609776 0.0 0.0 0.0 0.0 |
| Mitotic prophase 0.0 93.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitotic spindle checkpoint 1.0 111.0 1.861966604823748 0.4222664170554933 0.0 0.0 0.0 0.0 |
| Mitotic telophase cytokinesis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Modulation by mtb of host immune system 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molecules associated with elastic fibres 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molybdenum cofactor biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna capping 1.0 29.0 7.37463556851312 0.1330370821365251 0.0 0.0 0.0 0.0 |
| Mrna decay by 3 to 5 exoribonuclease 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna decay by 5 to 3 exoribonuclease 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna editing 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna editing c to u conversion 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna splicing 4.0 188.0 4.707939508506616 0.0133222812797909 0.0 0.0 0.0 0.0 |
| Mrna splicing minor pathway 1.0 52.0 4.039615846338536 0.2260688267312995 0.0 0.0 0.0 0.0 |
| Mtor signalling 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mtorc1 mediated signalling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mucopolysaccharidoses 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Multifunctional anion exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Muscle contraction 0.0 83.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myd88 independent tlr4 cascade 1.0 78.0 2.668698648290485 0.3194831905047319 0.0 0.0 0.0 0.0 |
| Myoclonic epilepsy of lafora 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myogenesis 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation in the medial trans golgi 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming and elongation in the cis golgi 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming in the er and calnexin calreticulin cycle 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Na cl dependent neurotransmitter transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nade modulates death signalling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ncam signaling for neurite out growth 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ncam1 interactions 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nectin necl trans heterodimerization 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neddylation 0.0 185.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef and signal transduction 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd4 down regulation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd8 down regulation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated downregulation of mhc class i complex cell surface expression 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative epigenetic regulation of rrna expression 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative feedback regulation of mapk pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of activity of tfap2 ap 2 family transcription factors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr1 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr2 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr3 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr4 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of flt3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of mapk pathway 1.0 36.0 5.895626822157435 0.1624541869963563 0.0 0.0 0.0 0.0 |
| Negative regulation of met activity 1.0 20.0 10.0 0.0937235599037543 0.0 0.0 0.0 0.0 |
| Negative regulation of nmda receptor mediated neuronal transmission 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of notch4 signaling 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by dvl interacting proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by wnt ligand antagonists 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of the pi3k akt network 1.0 62.0 3.3740381398461023 0.2633971592089756 0.0 0.0 0.0 0.0 |
| Negative regulators of ddx58 ifih1 signaling 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nephrin family interactions 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nervous system development 1.0 443.0 0.4480561455351371 0.8920949042483466 0.0 0.0 0.0 0.0 |
| Netrin 1 signaling 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Netrin mediated repulsion signals 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurexins and neuroligins 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurofascin interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neuronal system 0.0 177.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotoxicity of clostridium toxins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter clearance 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter receptors and postsynaptic signal transmission 0.0 105.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter release cycle 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neutrophil degranulation 1.0 319.0 0.6307277628032345 0.7967312730748517 0.0 0.0 0.0 0.0 |
| Nf kb activation through fadd rip 1 pathway mediated by caspase 8 and 10 1.0 13.0 10.0 0.0619434524836269 0.0 0.0 0.0 0.0 |
| Nf kb is activated and signals survival 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf independant trka activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf stimulated transcription 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nicotinamide salvaging 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nicotinate metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nitric oxide stimulates guanylate cyclase 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nod1 2 signaling pathway 1.0 30.0 7.11963406052076 0.1373006943976843 0.0 0.0 0.0 0.0 |
| Non integrin membrane ecm interactions 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Noncanonical activation of notch3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nonhomologous end joining nhej 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nonsense mediated decay nmd 1.0 110.0 1.8792360981089684 0.4193881110516689 0.0 0.0 0.0 0.0 |
| Norepinephrine neurotransmitter release cycle 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nostrin mediated enos trafficking 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch hlh transcription pathway 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch1 intracellular domain regulates transcription 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch2 activation and transmission of signal to the nucleus 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch2 intracellular domain regulates transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 activation and transmission of signal to the nucleus 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 intracellular domain regulates transcription 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 activation and transmission of signal to the nucleus 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 intracellular domain regulates transcription 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 and nr1h3 mediated signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to gluconeogenesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to lipogenesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to triglyceride lipolysis in adipose 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to control bile acid homeostasis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to limit cholesterol uptake 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h3 nr1h2 regulate gene expression linked to cholesterol transport and efflux 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrage signals death through jnk 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrcam interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrif signals cell death from the nucleus 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ns1 mediated effects on host pathways 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ntrk2 activates rac1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear envelope breakdown 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear envelope ne reassembly 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear events kinase and transcription factor activation 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear events stimulated by alk signaling in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear import of rev protein 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear pore complex npc disassembly 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear receptor transcription pathway 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear signaling by erbb4 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide binding domain leucine rich repeat containing receptor nlr signaling pathways 1.0 42.0 5.029865604778497 0.1868885334554594 0.0 0.0 0.0 0.0 |
| Nucleotide biosynthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide catabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide excision repair 1.0 114.0 1.811992053458552 0.4308176920885813 0.0 0.0 0.0 0.0 |
| Nucleotide like purinergic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide salvage 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| O glycosylation of tsr domain containing proteins 1.0 5.0 10.0 0.0242848323540905 0.0 0.0 0.0 0.0 |
| O linked glycosylation 1.0 35.0 6.069627851140456 0.1583124314184509 0.0 0.0 0.0 0.0 |
| O linked glycosylation of mucins 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oas antiviral response 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Olfactory signaling pathway 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogene induced senescence 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogenic mapk signaling 1.0 66.0 3.165149136577708 0.2778293030066073 0.0 0.0 0.0 0.0 |
| Opioid signalling 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Orc1 removal from chromatin 0.0 65.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organelle biogenesis and maintenance 0.0 268.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organic anion transporters 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organic cation anion zwitterion transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organic cation transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Other interleukin signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Other semaphorin interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ovarian tumor domain proteases 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oxidative stress induced senescence 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P130cas linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P2y receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P38mapk events 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75 ntr receptor mediated signalling 0.0 81.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr negatively regulates cell cycle via sc1 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr recruits signalling complexes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr regulates axonogenesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr signals via nf kb 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Parasite infection 0.0 50.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Passive transport by aquaporins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcna dependent long patch base excision repair 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcp ce pathway 0.0 78.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pd 1 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pecam1 interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pentose phosphate pathway 1.0 13.0 10.0 0.0619434524836269 0.0 0.0 0.0 0.0 |
| Peptide hormone metabolism 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peptide ligand binding receptors 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Perk regulates gene expression 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peroxisomal lipid metabolism 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peroxisomal protein import 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pexophagy 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 0 rapid depolarisation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 2 plateau phase 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 3 rapid repolarisation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 4 resting membrane potential 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase i functionalization of compounds 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase ii conjugation of compounds 1.0 53.0 3.9615384615384617 0.2298835505782255 0.0 0.0 0.0 0.0 |
| Phenylalanine and tyrosine metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phenylalanine metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by ntpdase proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by nudt proteins 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr2 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr4 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipid metabolism 1.0 156.0 1.3154707044107965 0.538277640080983 0.0 0.0 0.0 0.0 |
| Phosphorylation of emi1 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphorylation of the apc c 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Physiological factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr2 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi metabolism 1.0 71.0 2.9376093294460643 0.295480255529908 0.0 0.0 0.0 0.0 |
| Pi3k akt activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k akt signaling in cancer 1.0 58.0 3.612244897959184 0.2486824788491954 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb4 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi5p regulates tp53 acetylation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pink1 prkn mediated mitophagy 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Piwi interacting rna pirna biogenesis 1.0 16.0 10.0 0.0756950383436983 0.0 0.0 0.0 0.0 |
| Pka activation in glucagon signalling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of creb 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of key metabolic factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pkmts methylate histone lysines 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly remodeling and clearance 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein clearance 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein remodeling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet activation signaling and aggregation 1.0 152.0 1.3508582240843356 0.528966667701962 0.0 0.0 0.0 0.0 |
| Platelet adhesion to exposed collagen 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet aggregation plug formation 1.0 20.0 10.0 0.0937235599037543 0.0 0.0 0.0 0.0 |
| Platelet calcium homeostasis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet homeostasis 1.0 51.0 4.120816326530612 0.2222355866483168 0.0 0.0 0.0 0.0 |
| Platelet sensitization by ldl 1.0 15.0 10.0 0.0711332726649859 0.0 0.0 0.0 0.0 |
| Polb dependent long patch base excision repair 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polo like kinase mediated events 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polymerase switching 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polymerase switching on the c strand of the telomere 1.0 28.0 7.648526077097506 0.1287528218161406 0.0 0.0 0.0 0.0 |
| Positive epigenetic regulation of rrna expression 1.0 60.0 3.4891041162227605 0.2560754722464486 0.0 0.0 0.0 0.0 |
| Post chaperonin tubulin folding pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post translational modification synthesis of gpi anchored proteins 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post translational protein modification 4.0 1003.0 0.7961874918396658 0.7383918284169381 0.0 0.0 0.0 0.0 |
| Postmitotic nuclear pore complex npc reformation 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Potassium channels 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Potential therapeutics for sars 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog activate genes related to proliferation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog repress genes related to differentiation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pp2a mediated dephosphorylation of key metabolic factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prc2 methylates histones and dna 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch expression and processing 0.0 50.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch processing in golgi 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch processing in the endoplasmic reticulum 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pregnenolone biosynthesis 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic depolarization and calcium channel opening 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic function of kainate receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prevention of phagosomal lysosomal fusion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing and activation of sumo 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of capped intron containing pre mrna 4.0 239.0 3.667345050878816 0.0292338983797676 0.0 0.0 0.0 0.0 |
| Processing of capped intronless pre mrna 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of dna double strand break ends 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of intronless pre mrnas 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of smdt1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processive synthesis on the c strand of the telomere 1.0 21.0 10.0 0.0981765691424607 0.0 0.0 0.0 0.0 |
| Processive synthesis on the lagging strand 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Programmed cell death 0.0 179.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prolactin receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prolonged erk activation events 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Propionyl coa catabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prostacyclin signalling through prostacyclin receptor 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein folding 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein localization 0.0 142.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein protein interactions at synapses 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein repair 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein ubiquitination 1.0 58.0 3.612244897959184 0.2486824788491954 0.0 0.0 0.0 0.0 |
| Proton coupled monocarboxylate transport 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pten regulation 0.0 128.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 expression 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 promotes hif1a stabilization 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates cell cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates proteins involved in rna processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rho gtpases ras gtpase and map kinases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rtks and their effectors akt1 and dok1 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine catabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine ribonucleoside monophosphate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine salvage 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purinergic signaling in leishmaniasis infection 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyrimidine catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyrimidine salvage 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyroptosis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism 1.0 26.0 8.26204081632653 0.1201219647894398 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism and citric acid tca cycle 1.0 48.0 4.385149804602692 0.2106238865633207 0.0 0.0 0.0 0.0 |
| Ra biosynthesis pathway 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rab gefs exchange gtp for gdp on rabs 1.0 79.0 2.634222919937206 0.3228460923172884 0.0 0.0 0.0 0.0 |
| Rab geranylgeranylation 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rab regulation of trafficking 2.0 107.0 3.9845238095238096 0.0966324665930835 0.0 0.0 0.0 0.0 |
| Rac1 gtpase cycle 0.0 152.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rac2 gtpase cycle 0.0 81.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rac3 gtpase cycle 0.0 83.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Raf activation 1.0 33.0 6.450255102040816 0.1499686155438198 0.0 0.0 0.0 0.0 |
| Raf independent mapk1 3 activation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rap1 signalling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras activation upon ca2 influx through nmda receptor 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras processing 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras signaling downstream of nf1 loss of function variants 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reactions specific to the complex n glycan synthesis pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Receptor mediated mitophagy 1.0 10.0 10.0 0.0479914252810258 0.0 0.0 0.0 0.0 |
| Receptor type tyrosine protein phosphatases 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recognition and association of dna glycosylase with site containing an affected purine 1.0 16.0 10.0 0.0756950383436983 0.0 0.0 0.0 0.0 |
| Recognition of dna damage by pcna containing replication complex 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recruitment of mitotic centrosome proteins and complexes 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recruitment of numa to mitotic centrosomes 0.0 90.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling of bile acids and salts 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling of eif2 gdp 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling pathway of l1 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reduction of cytosolic ca levels 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reelin signalling pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated necrosis 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated proteolysis of p75ntr 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation by c flip 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of bach1 activity 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of beta cell development 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cholesterol biosynthesis by srebp srebf 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of commissural axon pathfinding by slit and robo 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cytoskeletal remodeling and cell spreading by ipp complex components 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of expression of slits and robos 1.0 155.0 1.3241452425125897 0.5359669486531639 0.0 0.0 0.0 0.0 |
| Regulation of foxo transcriptional activity by acetylation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of fzd by ubiquitination 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression by hypoxia inducible factor 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in beta cells 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in early pancreatic precursor cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in late stage branching morphogenesis pancreatic bud precursor cells 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of glucokinase by glucokinase regulatory protein 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of glycolysis by fructose 2 6 bisphosphate metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of hmox1 expression and activity 0.0 58.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of hsf1 mediated heat shock response 1.0 76.0 2.740408163265306 0.312708212996757 0.0 0.0 0.0 0.0 |
| Regulation of ifna signaling 1.0 8.0 10.0 0.0385773062479974 0.0 0.0 0.0 0.0 |
| Regulation of ifng signaling 1.0 10.0 10.0 0.0479914252810258 0.0 0.0 0.0 0.0 |
| Regulation of innate immune responses to cytosolic dna 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of insulin like growth factor igf transport and uptake by insulin like growth factor binding proteins igfbps 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of insulin secretion 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of kit signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of lipid metabolism by pparalpha 0.0 95.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of localization of foxo transcription factors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of mecp2 expression and activity 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of mrna stability by proteins that bind au rich elements 1.0 79.0 2.634222919937206 0.3228460923172884 0.0 0.0 0.0 0.0 |
| Regulation of plk1 activity at g2 m transition 0.0 87.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten gene transcription 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten localization 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten mrna translation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten stability and activity 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pyruvate dehydrogenase pdh complex 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of ras by gaps 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx1 expression and activity 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx2 expression and activity 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx3 expression and activity 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of signaling by cbl 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of signaling by nodal 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tlr by endogenous ligand 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tnfr1 signaling 1.0 31.0 6.881632653061224 0.141543756104335 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity 1.0 146.0 1.407600281491907 0.5146542249230733 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through acetylation 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through association with co factors 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through phosphorylation 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 expression and degradation 1.0 33.0 6.450255102040816 0.1499686155438198 0.0 0.0 0.0 0.0 |
| Release of apoptotic factors from the mitochondria 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Release of hh np from the secreting cell 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Removal of aminoterminal propeptides from gamma carboxylated proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Repression of wnt target genes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reproduction 1.0 57.0 3.677113702623907 0.2449590299452383 0.0 0.0 0.0 0.0 |
| Resolution of abasic sites ap sites 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of ap sites via the multiple nucleotide patch replacement pathway 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures through synthesis dependent strand annealing sdsa 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of sister chromatid cohesion 1.0 120.0 1.7196021265649115 0.4475497772550058 0.0 0.0 0.0 0.0 |
| Respiratory electron transport 0.0 101.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Respiratory electron transport atp synthesis by chemiosmotic coupling and heat production by uncoupling proteins 0.0 116.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response of eif2ak1 hri to heme deficiency 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response of eif2ak4 gcn2 to amino acid deficiency 1.0 94.0 2.206056616194865 0.3713777336871285 0.0 0.0 0.0 0.0 |
| Response of mtb to phagocytosis 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response to elevated platelet cytosolic ca2 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response to metal ions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ret signaling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retinoid cycle disease events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retrograde neurotrophin signalling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retrograde transport at the trans golgi network 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reversible hydration of carbon dioxide 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpase cycle 0.0 387.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpase effectors 1.0 246.0 0.8247396917950853 0.7059857251491578 0.0 0.0 0.0 0.0 |
| Rho gtpases activate cit 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate formins 1.0 133.0 1.548237476808905 0.4821661790408554 0.0 0.0 0.0 0.0 |
| Rho gtpases activate iqgaps 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate ktn1 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate nadph oxidases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate paks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate pkns 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rhotekin and rhophilins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rocks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate wasps and waves 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoa gtpase cycle 0.0 134.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhob gtpase cycle 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb gtpase cycle 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb1 gtpase cycle 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb2 gtpase cycle 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb3 atpase cycle 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoc gtpase cycle 0.0 75.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhod gtpase cycle 0.0 50.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhof gtpase cycle 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhog gtpase cycle 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoh gtpase cycle 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoj gtpase cycle 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoq gtpase cycle 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhot1 gtpase cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhou gtpase cycle 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhov gtpase cycle 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rip mediated nfkb activation via zbp1 1.0 16.0 10.0 0.0756950383436983 0.0 0.0 0.0 0.0 |
| Ripk1 mediated regulated necrosis 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rmts methylate histone arginines 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i promoter escape 1.0 42.0 5.029865604778497 0.1868885334554594 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription 1.0 63.0 3.3192890059249507 0.2670314735990955 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription initiation 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription termination 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcribes snrna genes 1.0 73.0 2.8554421768707483 0.3024216363859021 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription 6.0 969.0 1.300339847068819 0.3380683130437211 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription termination 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii chain elongation 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 1 promoter 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 3 promoter 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription termination 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rnd1 gtpase cycle 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rnd2 gtpase cycle 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rnd3 gtpase cycle 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Robo receptors bind akap5 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of abl in robo slit signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of lat2 ntal lab on calcium mobilization 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of phospholipids in phagocytosis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of second messengers in netrin 1 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rora activates gene expression 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ros and rns production in phagocytes 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna modification in the mitochondrion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna modification in the nucleus and cytosol 1.0 63.0 3.3192890059249507 0.2670314735990955 0.0 0.0 0.0 0.0 |
| Rrna processing 3.0 202.0 3.190527103603122 0.0762657298482616 0.0 0.0 0.0 0.0 |
| Rrna processing in the mitochondrion 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rsk activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 and foxp3 control the development of regulatory t lymphocytes tregs 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 interacts with co factors whose precise effect on runx1 targets is not known 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates estrogen receptor mediated transcription 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates expression of components of tight junctions 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates genes involved in megakaryocyte differentiation and platelet function 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in bcr signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of hscs 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of keratinocytes 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of myeloid cells 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in interleukin signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in wnt signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates bone development 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates chondrocyte maturation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates genes involved in cell migration 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates osteoblast differentiation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates bcl2l11 bim transcription 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates cdkn1a transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates immune response and cell migration 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates notch signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates p14 arf 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates wnt signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates yap1 mediated transcription 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| S phase 0.0 158.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sars cov 1 infection 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sars cov 2 infection 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sars cov infections 0.0 128.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging by class a receptors 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging by class b receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging by class f receptors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging of heme from plasma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scf skp2 mediated degradation of p27 p21 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sealing of the nuclear envelope ne by escrt iii 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Selective autophagy 1.0 67.0 3.116883116883117 0.2813938178053637 0.0 0.0 0.0 0.0 |
| Selenoamino acid metabolism 1.0 107.0 1.932999614940316 0.410668613679594 0.0 0.0 0.0 0.0 |
| Sema3a pak dependent axon repulsion 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema3a plexin repulsion signaling by inhibiting integrin adhesion 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d in semaphorin signaling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d induced cell migration and growth cone collapse 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d mediated inhibition of cell attachment and migration 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Semaphorin interactions 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Senescence associated secretory phenotype sasp 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensing of dna double strand breaks 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory perception 0.0 84.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory perception of taste 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory processing of sound 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory processing of sound by outer hair cells of the cochlea 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Separation of sister chromatids 1.0 179.0 1.1428571428571428 0.5884175149817239 0.0 0.0 0.0 0.0 |
| Serine biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Serotonin neurotransmitter release cycle 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc related events triggered by igf1r 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in egfr signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb2 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb4 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sialic acid metabolism 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal amplification 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal attenuation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal regulatory protein family interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal transduction by l1 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by activin 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by alk 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by alk in cancer 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by bmp 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by braf and raf1 fusions 1.0 53.0 3.9615384615384617 0.2298835505782255 0.0 0.0 0.0 0.0 |
| Signaling by csf3 g csf 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ctnnb1 phospho site mutants 1.0 15.0 10.0 0.0711332726649859 0.0 0.0 0.0 0.0 |
| Signaling by cytosolic fgfr1 fusion mutants 1.0 18.0 10.0 0.0847528009868792 0.0 0.0 0.0 0.0 |
| Signaling by egfr 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by egfr in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 ecd mutants 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb4 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erythropoietin 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr 1.0 57.0 3.677113702623907 0.2449590299452383 0.0 0.0 0.0 0.0 |
| Signaling by fgfr in disease 2.0 48.0 9.148550724637682 0.0230307909850112 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 in disease 1.0 29.0 7.37463556851312 0.1330370821365251 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 1.0 51.0 4.120816326530612 0.2222355866483168 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 iiia tm 1.0 18.0 10.0 0.0847528009868792 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 in disease 1.0 28.0 7.648526077097506 0.1287528218161406 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 fusions in cancer 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 in disease 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by flt3 fusion proteins 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by flt3 itd and tkd mutants 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by gpcr 0.0 204.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by hedgehog 0.0 122.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by hippo 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by insulin receptor 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by interleukins 1.0 248.0 0.8178963893249608 0.7089333658227114 0.0 0.0 0.0 0.0 |
| Signaling by kit in disease 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by leptin 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by lrp5 mutants 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mapk mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by membrane tethered fusions of pdgfra or pdgfrb 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by met 1.0 64.0 3.266277939747328 0.270648213584465 0.0 0.0 0.0 0.0 |
| Signaling by moderate kinase activity braf mutants 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mras complex mutants 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mst1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by nodal 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch 0.0 152.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 hd domain mutants in cancer 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 pest domain mutants in cancer 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 t 7 9 notch1 m1580 k2555 translocation mutant 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch2 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch3 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch4 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrk2 trkb 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrk3 trkc 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrks 0.0 102.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by nuclear receptors 2.0 178.0 2.3603219696969697 0.2170623616565413 0.0 0.0 0.0 0.0 |
| Signaling by pdgf 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgfr in disease 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgfra transmembrane juxtamembrane and kinase domain mutants 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ptk6 1.0 36.0 5.895626822157435 0.1624541869963563 0.0 0.0 0.0 0.0 |
| Signaling by receptor tyrosine kinases 3.0 344.0 1.835340363137206 0.237646181693679 0.0 0.0 0.0 0.0 |
| Signaling by retinoic acid 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by rho gtpases miro gtpases and rhobtb3 1.0 593.0 0.3293574186431329 0.95038394647897 0.0 0.0 0.0 0.0 |
| Signaling by rnf43 mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by robo receptors 1.0 197.0 1.0360266555601834 0.6238979592774339 0.0 0.0 0.0 0.0 |
| Signaling by scf kit 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex in cancer 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgfb family members 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by the b cell receptor bcr 1.0 91.0 2.2802721088435374 0.3619523256513019 0.0 0.0 0.0 0.0 |
| Signaling by type 1 insulin like growth factor 1 receptor igf1r 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by vegf 1.0 87.0 2.387280493592786 0.3491693980885609 0.0 0.0 0.0 0.0 |
| Signaling by wnt 1.0 213.0 0.9562957258375048 0.6529074687195162 0.0 0.0 0.0 0.0 |
| Signaling by wnt in cancer 1.0 25.0 8.607142857142858 0.1157751708195439 0.0 0.0 0.0 0.0 |
| Signalling to erks 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to p38 via rit and rin 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to ras 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sirt1 negatively regulates rrna expression 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slbp dependent processing of replication dependent histone pre mrnas 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slc mediated transmembrane transport 0.0 101.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slc transporter disorders 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smac xiap regulated apoptotic response 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smad2 smad3 smad4 heterotrimer regulates transcription 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Small interfering rna sirna biogenesis 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smooth muscle contraction 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Snrnp assembly 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium calcium exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium coupled phosphate cotransporters 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium proton exchangers 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sos mediated signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sperm motility and taxes 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sphingolipid de novo biosynthesis 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sphingolipid metabolism 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Spry regulation of fgf signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Srp dependent cotranslational protein targeting to membrane 1.0 108.0 1.9147434674804504 0.4135892767062017 0.0 0.0 0.0 0.0 |
| Stabilization of p53 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat3 nuclear events downstream of alk signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat5 activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat5 activation downstream of flt3 itd mutants 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stimuli sensing channels 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sting mediated induction of host immune responses 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Striated muscle contraction 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sulfide oxidation to sulfate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sulfur amino acid metabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is conjugated to e1 uba2 sae1 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is proteolytically processed 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is transferred from e1 to e2 ube2i ubc9 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation 1.0 155.0 1.3241452425125897 0.5359669486531639 0.0 0.0 0.0 0.0 |
| Sumoylation of chromatin organization proteins 1.0 58.0 3.612244897959184 0.2486824788491954 0.0 0.0 0.0 0.0 |
| Sumoylation of dna damage response and repair proteins 0.0 76.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of dna methylation proteins 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of dna replication proteins 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of immune response proteins 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of intracellular receptors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of rna binding proteins 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of sumoylation proteins 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription cofactors 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription factors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of ubiquitinylation proteins 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Suppression of apoptosis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Suppression of phagosomal maturation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Surfactant metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Switching of origins to a post replicative state 0.0 85.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synaptic adhesion like molecules 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Syndecan interactions 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 12 eicosatetraenoic acid derivatives 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 15 eicosatetraenoic acid derivatives 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 16 20 hydroxyeicosatetraenoic acids hete 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 5 eicosatetraenoic acids 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of active ubiquitin roles of e1 and e2 enzymes 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts 1.0 20.0 10.0 0.0937235599037543 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 24 hydroxycholesterol 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 27 hydroxycholesterol 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 7alpha hydroxycholesterol 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of diphthamide eef2 1.0 8.0 10.0 0.0385773062479974 0.0 0.0 0.0 0.0 |
| Synthesis of dna 0.0 117.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of dolichyl phosphate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of epoxy eet and dihydroxyeicosatrienoic acids dhet 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of gdp mannose 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of glycosylphosphatidylinositol gpi 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip2 ip and ins in the cytosol 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip3 and ip4 in the cytosol 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ketone bodies 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of leukotrienes lt and eoxins ex 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of lipoxins lx 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pa 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pc 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pe 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pg 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pi 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the early endosome membrane 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the er membrane 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the golgi membrane 1.0 15.0 10.0 0.0711332726649859 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the late endosome membrane 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the plasma membrane 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of prostaglandins pg and thromboxanes tx 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pyrophosphates in the cytosol 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of substrates in n glycan biosythesis 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of udp n acetyl glucosamine 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of very long chain fatty acyl coas 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of wybutosine at g37 of trna phe 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and deacylation of ghrelin 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucagon like peptide 1 glp 1 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucose dependent insulinotropic polypeptide gip 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tak1 activates nfkb by phosphorylation and activation of ikks complex 1.0 25.0 8.607142857142858 0.1157751708195439 0.0 0.0 0.0 0.0 |
| Tandem pore domain potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tbc rabgaps 1.0 39.0 5.428571428571429 0.1747599807978781 0.0 0.0 0.0 0.0 |
| Tcf dependent signaling in response to wnt 1.0 142.0 1.44811115935736 0.50487672715324 0.0 0.0 0.0 0.0 |
| Tcr signaling 1.0 85.0 2.444606413994169 0.3426841548479852 0.0 0.0 0.0 0.0 |
| Telomere c strand lagging strand synthesis 1.0 37.0 5.7312925170068025 0.1665759675679584 0.0 0.0 0.0 0.0 |
| Telomere c strand synthesis initiation 1.0 13.0 10.0 0.0619434524836269 0.0 0.0 0.0 0.0 |
| Telomere extension by telomerase 1.0 21.0 10.0 0.0981765691424607 0.0 0.0 0.0 0.0 |
| Telomere maintenance 2.0 74.0 5.829861111111111 0.0508992589190798 0.0 0.0 0.0 0.0 |
| Terminal pathway of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of o glycan biosynthesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of translesion dna synthesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tetrahydrobiopterin bh4 synthesis recycling salvage and regulation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of cell cycle factors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of growth factors and their receptors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2a acts as a transcriptional repressor during retinoic acid induced cell differentiation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling activates smads 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling in emt epithelial to mesenchymal transition 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The activation of arylsulfatases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The canonical retinoid cycle in rods twilight vision 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The citric acid tca cycle and respiratory electron transport 1.0 160.0 1.2818636888717752 0.5474081709152836 0.0 0.0 0.0 0.0 |
| The fatty acid cycling model 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The nlrp3 inflammasome 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The phototransduction cascade 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The retinoid cycle in cones daylight vision 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The role of gtse1 in g2 m progression after g2 checkpoint 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The role of nef in hiv 1 replication and disease pathogenesis 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thrombin signalling through proteinase activated receptors pars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thromboxane signalling through tp receptor 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 dependent activation of irf3 irf7 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 rip1 mediated ikk complex recruitment 1.0 16.0 10.0 0.0756950383436983 0.0 0.0 0.0 0.0 |
| Ticam1 traf6 dependent induction of tak1 complex 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tie2 signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tight junction interactions 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tlr3 mediated ticam1 dependent programmed cell death 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf receptor superfamily tnfsf members mediating non canonical nf kb pathway 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf signaling 1.0 39.0 5.428571428571429 0.1747599807978781 0.0 0.0 0.0 0.0 |
| Tnfr1 induced nfkappab signaling pathway 1.0 28.0 7.648526077097506 0.1287528218161406 0.0 0.0 0.0 0.0 |
| Tnfr1 induced proapoptotic signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 mediated ceramide production 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr2 non canonical nf kb pathway 1.0 58.0 3.612244897959184 0.2486824788491954 0.0 0.0 0.0 0.0 |
| Tnfs bind their physiological receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor 9 tlr9 cascade 1.0 75.0 2.7777164920022064 0.3092959809067388 0.0 0.0 0.0 0.0 |
| Toll like receptor cascades 1.0 103.0 2.009603841536615 0.3988427362229673 0.0 0.0 0.0 0.0 |
| Toll like receptor tlr1 tlr2 cascade 1.0 70.0 2.980479148181012 0.2919842266274133 0.0 0.0 0.0 0.0 |
| Toxicity of botulinum toxin type d botd 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates metabolic genes 0.0 84.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of caspase activators and caspases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell cycle genes 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell death genes 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of death receptors and ligands 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of dna repair genes 1.0 61.0 3.4306122448979592 0.2597451867723493 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in cytochrome c release 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g1 cell cycle arrest 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g2 cell cycle arrest 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of several additional cell death genes whose specific roles in p53 dependent apoptosis remain uncertain 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf3 dependent irf activation pathway 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated induction of tak1 complex within tlr4 complex 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation in tlr7 8 or 9 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated nf kb activation 1.0 22.0 9.839650145772596 0.1026081339138497 0.0 0.0 0.0 0.0 |
| Trafficking and processing of endosomal tlr 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of ampa receptors 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of glur2 containing ampa receptors 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of myristoylated proteins to the cilium 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trail signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trans golgi network vesicle budding 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription coupled nucleotide excision repair tc ner 1.0 82.0 2.5359032501889645 0.3328373805982222 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by dream complex 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by p107 rbl1 and p130 rbl2 in complex with hdac1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of the hiv genome 1.0 67.0 3.116883116883117 0.2813938178053637 0.0 0.0 0.0 0.0 |
| Transcriptional activation of mitochondrial biogenesis 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional activity of smad2 smad3 smad4 heterotrimer 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by e2f6 2.0 34.0 10.0 0.0119629297909749 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by mecp2 1.0 45.0 4.6855287569573285 0.1988423464133734 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx1 0.0 149.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx2 0.0 100.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx3 0.0 86.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by small rnas 1.0 57.0 3.677113702623907 0.2449590299452383 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by the ap 2 tfap2 family of transcription factors 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by tp53 2.0 333.0 1.2355236656596174 0.4894923480837373 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by ventx 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of granulopoiesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of pluripotent stem cells 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of testis differentiation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of white adipocyte differentiation 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transferrin endocytosis and recycling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation 5.0 289.0 3.8583724569640063 0.0132177007724255 0.0 0.0 0.0 0.0 |
| Translation of replicase and assembly of the replication transcription complex 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation of sars cov 1 structural proteins 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation of sars cov 2 structural proteins 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polh 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polk 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by y family dna polymerases bypasses lesions on dna template 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translocation of slc2a4 glut4 to the plasma membrane 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transmission across chemical synapses 0.0 139.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport and synthesis of paps 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of bile salts and organic acids metal ions and amine compounds 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of connexons to the plasma membrane 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of fatty acids 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of inorganic cations anions and amino acids oligopeptides 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of mature mrnas derived from intronless transcripts 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of mature transcript to cytoplasm 0.0 81.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of nucleotide sugars 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of organic anions 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of small molecules 0.0 377.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of the slbp dependant mature mrna 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of vitamins nucleosides and related molecules 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport to the golgi and subsequent modification 0.0 148.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trif mediated programmed cell death 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride catabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride metabolism 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tristetraprolin ttp zfp36 binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna aminoacylation 1.0 43.0 4.909620991253644 0.1908924307699622 0.0 0.0 0.0 0.0 |
| Trna modification in the mitochondrion 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna modification in the nucleus and cytosol 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing 0.0 109.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing in the mitochondrion 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing in the nucleus 0.0 60.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trp channels 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tryptophan catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Type i hemidesmosome assembly 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tyrosine catabolism 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tysnd1 cleaves peroxisomal proteins 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ub specific processing proteases 0.0 151.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ubiquinol biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uch proteinases 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Unblocking of nmda receptors glutamate binding and activation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Unfolded protein response upr 0.0 75.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Unwinding of dna 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and actions of bacterial toxins 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and function of anthrax toxins 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and function of diphtheria toxin 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Urea cycle 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vasopressin regulates renal water homeostasis via aquaporins 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegf ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated cell proliferation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated vascular permeability 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vesicle mediated transport 2.0 546.0 0.7354473039215687 0.7564243546557855 0.0 0.0 0.0 0.0 |
| Viral messenger rna synthesis 1.0 44.0 4.794969150450879 0.1948770046367652 0.0 0.0 0.0 0.0 |
| Visual phototransduction 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b1 thiamin metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b2 riboflavin metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b5 pantothenate metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin c ascorbate metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin d calciferol metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldl assembly 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldl clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldlr internalisation and degradation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Voltage gated potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vxpx cargo targeting to cilium 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wax and plasmalogen biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt ligand biogenesis and trafficking 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt mediated activation of dvl 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd2 fzd5 and ror2 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd4 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Xenobiotics 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Yap1 and wwtr1 taz stimulated gene expression 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zbp1 dai mediated induction of type i ifns 1.0 18.0 10.0 0.0847528009868792 0.0 0.0 0.0 0.0 |
| Zinc efflux and compartmentalization by the slc30 family 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc influx into cells by the slc39 gene family 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc transporters 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
|
|
